Literature DB >> 25823917

Integration of the full-length HPV16 genome in cervical cancer and Caski and Siha cell lines and the possible ways of HPV integration.

Feng Xu1, Meng Cao, Qinfeng Shi, Hongwei Chen, Yili Wang, Xu Li.   

Abstract

Integration of high-risk human papillomavirus (HPV) into the host genome is a key event for cervical carcinogenesis. Different methods have been used to explore the physical states of the HPV genome to reveal the mechanisms for malignant transformation of the infected cells. Consensus has been reached that, although variable portions of the HPV genome are deleted in the integrated HPV sequences, common disruption of the viral E2 gene has been demonstrated in different studies. The head-to-tail concatemers of the full-length HPV16 genome is another typical integration pattern of HPV16, typically found in Caski cell lines, but its prevalence in cervical cancer has never been tested. Here, by introducing a modified PCR, we identified this head-to-tail concatemers of full-length HPV genomes in advanced cervical cancer with HPV16 single positive. Our results show that more than half of the cases contain this integrated head-to-tail concatemers of full-length HPV16 genomes. Further studies in two cervical cell lines, Caski cells and Siha cells, revealed a correlation between the prevalence of the spliced variants of integrated HPV16 sequences and the full-length transcription of the integrated head-to-tail concatemers of the full-length HPV16 genome. Based on these results, we propose that HPV16 integrated into host cells by two mechanisms: one mechanism is shared by other DNA virus and cause integration of the head-to-tail concatemers of the viral genome; another is related to the reverse transcription process, which the integrated HPV sequence is generated by the reverse transcription of the viral mRNA.

Entities:  

Mesh:

Year:  2015        PMID: 25823917     DOI: 10.1007/s11262-014-1164-7

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  20 in total

1.  Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract.

Authors:  H Lehn; L L Villa; F Marziona; M Hilgarth; H G Hillemans; G Sauer
Journal:  J Gen Virol       Date:  1988-01       Impact factor: 3.891

2.  Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation.

Authors:  K Cooper; C S Herrington; J E Stickland; M F Evans; J O McGee
Journal:  J Clin Pathol       Date:  1991-12       Impact factor: 3.411

Review 3.  Splicing of messenger RNA precursors.

Authors:  R A Padgett; P J Grabowski; M M Konarska; S Seiler; P A Sharp
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

4.  Human papillomavirus status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment.

Authors:  K Lindel; P Burri; H U Studer; H J Altermatt; R H Greiner; G Gruber
Journal:  Int J Gynecol Cancer       Date:  2005 Mar-Apr       Impact factor: 3.437

5.  Clonal selection for transcriptionally active viral oncogenes during progression to cancer.

Authors:  Brian A Van Tine; John C Kappes; N Sanjib Banerjee; Judith Knops; Lilin Lai; Renske D M Steenbergen; Chris L J M Meijer; Peter J F Snijders; Pamela Chatis; Thomas R Broker; Phillip T Moen; Louise T Chow
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours.

Authors:  M Dürst; A Kleinheinz; M Hotz; L Gissmann
Journal:  J Gen Virol       Date:  1985-07       Impact factor: 3.891

7.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.

Authors:  M Dürst; L Gissmann; H Ikenberg; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas.

Authors:  Bo Xu; Sasithorn Chotewutmontri; Stephan Wolf; Ursula Klos; Martina Schmitz; Matthias Dürst; Elisabeth Schwarz
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

9.  Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer.

Authors:  Shirish Shukla; Sutapa Mahata; Gauri Shishodia; Shailja Pande; Gaurav Verma; Suresh Hedau; Suresh Bhambhani; Archana Kumari; Swaraj Batra; Seemi F Basir; Bhudev C Das; Alok C Bharti
Journal:  Indian J Med Res       Date:  2014-04       Impact factor: 2.375

10.  A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer.

Authors:  M Boshart; L Gissmann; H Ikenberg; A Kleinheinz; W Scheurlen; H zur Hausen
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

View more
  12 in total

1.  Integration sites of human papillomavirus 18 in esophageal cancer samples.

Authors:  Shuying Li; Zhanjun Liu; Jianghong Yan; Shangbo Sun; Xiaoli Hou; Dianqing Liu; Ke Zhang; Jin-Tao Li
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

2.  Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.

Authors:  Irene Lo Cigno; Federica Calati; Cinzia Borgogna; Alessandra Zevini; Silvia Albertini; Licia Martuscelli; Marco De Andrea; John Hiscott; Santo Landolfo; Marisa Gariglio
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

3.  The correlation between HLA-DRB1 and HLA-DQB1 gene polymorphisms and cytokines in HPV16 infected women with advanced cervical cancer.

Authors:  Yan Liu; Jian Zhang; Zhong-Ming Jia; Ji-Chang Li; Chun-Hua Dong; Yong-Mei Li
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  CDK6 increases glycolysis and suppresses autophagy by mTORC1-HK2 pathway activation in cervical cancer cells.

Authors:  Xiaoxi Zhang; Yunxia Sun; Siyao Cheng; Yanjing Yao; Xintao Hua; Yueyue Shi; Xiaoqin Jin; Jieli Pan; Miaofen G Hu; Pian Ying; Xiaoli Hou; Daozong Xia
Journal:  Cell Cycle       Date:  2022-02-15       Impact factor: 5.173

5.  Analysis of E2 gene integrity in HPV16 and HPV58 viruses isolated from women with cervical pathology.

Authors:  María Del R González-Losa; Marylin Puerto-Solis; Juan Tenorio Ruiz; Ariel I Rosado-López; Oscar Hau-Aviles; Guadalupe Ayora-Talavera; Isidro Cisneros-Cutz; Laura Conde-Ferráez
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-10-31       Impact factor: 2.743

6.  Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells.

Authors:  Ilaria Bacigalupo; Clelia Palladino; Patrizia Leone; Elena Toschi; Cecilia Sgadari; Barbara Ensoli; Giovanni Barillari
Journal:  Oncol Lett       Date:  2017-03-09       Impact factor: 2.967

Review 7.  Novel insights into epigenetic drivers of oropharyngeal squamous cell carcinoma: role of HPV and lifestyle factors.

Authors:  Paolo Boscolo-Rizzo; Carlo Furlan; Valentina Lupato; Jerry Polesel; Elisabetta Fratta
Journal:  Clin Epigenetics       Date:  2017-11-28       Impact factor: 6.551

Review 8.  Oxidative stress in female cancers.

Authors:  Gloria M Calaf; Ulises Urzua; Lara Termini; Francisco Aguayo
Journal:  Oncotarget       Date:  2018-05-04

9.  CRISPR-typing PCR (ctPCR), a new Cas9-based DNA detection method.

Authors:  Qiao Wang; Beibei Zhang; Xinhui Xu; Feifei Long; Jinke Wang
Journal:  Sci Rep       Date:  2018-09-20       Impact factor: 4.379

10.  Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma.

Authors:  Nicole V Anayannis; Nicolas F Schlecht; Miriam Ben-Dayan; Richard V Smith; Thomas J Belbin; Thomas J Ow; Duk M Blakaj; Robert D Burk; Sarah M Leonard; Ciaran B Woodman; Joanna L Parish; Michael B Prystowsky
Journal:  PLoS One       Date:  2018-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.